MedTrace Logo

Role of Prophylactic Tranexamic Acid in Reducing Blood Loss During Elective Caesarean Section for Placenta Praevia Major

NCT04350645 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-01-12

No results posted yet for this study

Summary

Prophylactic tranexamic acid will reduce blood loss during Caesarean section for placenta praevia

Conditions

  • Hemorrhage From Placenta Previa, With Delivery

Interventions

DRUG

Tranexamic acid injection

1g slow bolus of tranexamic acid over 2 minutes

DRUG

Normal Saline 0.9%

10mls normal saline 0.9% over 2 minutes

Sponsors & Collaborators

  • Universiti Kebangsaan Malaysia Medical Centre

    lead OTHER

Principal Investigators

  • Kah Teik Chew · UKM Medical Centre

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-24
Primary Completion
2021-12-23
Completion
2021-12-23

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04350645 on ClinicalTrials.gov